Transcranial Direct Current Stimulation for Migraine Attack

Not Applicable

Completed

• Conditions: Acute Migraine
• Interventions: Procedure: transcranial direct current stimulation

• Registration Number: NCT01358279
• Lead Sponsor: Seoul National University Hospital

Brief Summary

This study is conducted to investigate the therapeutic efficacy and safety of transcranial direct current stimulation (tDCS) over the primary motor cortex of patients with acute migraine attack.

Detailed Description

Not available

Study Timeline

• Study Start: 2009-01
• Primary Completion: 2009-10
• Study Completion: 2011-03
• Study First Submitted: 2011-05-18
• Study First Submitted QC: 2011-05-20
• Study First Posted: 2011-05-23
• Status Verified: 2016-10
• Last Update Submitted: 2016-10-23
• Last Update Posted: 2016-10-25

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 32

Inclusion Criteria

• Aged 17-70 years

• Migraine

  • With or without aura
  • The first attack of migraine was earlier than 50 years of age
  • One to 8 moderate to severe migraine attacks per month in the 2 months preceding the screening

• Willing and able to give written informed consent

• Able to read, comprehend and complete the diary form

Exclusion Criteria

• Not able to distinguish between migraine and non-migraine headache
• Combined headache, including the tension type headache and medication overuse headache
• Pregnant, actively trying to become pregnant or breast-feeding women
• Uncontrolled and significant medical illness
• Vertebrobasilar or hemiplegic migraine according to the International Headache Society diagnostic criteria
• Having intracranial metal implants or a cardiac pacemaker
• A history of epilepsy or other organic brain disorders
• A history of psychological diseases
• Having changed medications for migraine within 1 month before giving us informed consent
• Drug abuser or alcoholics

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
migraine	transcranial direct current stimulation	-

Primary Outcome Measures

Name	Time	Method
Number of participants who experienced pain relief of one level or more	at 2h post-treatment

Trial Locations

Locations (1)

Seoul National University Hospital; 🇰🇷 Seoul, Korea, Republic of